Center for Scientific Review Notice of Closed Meetings
Summary
The NIH Center for Scientific Review published a notice announcing five closed meetings scheduled for May 5-7, 2026, to review and evaluate grant applications for mentored training, cancer research, infertility technologies, and research excellence awards. The meetings will be held virtually and closed to the public under Federal Advisory Committee Act exemptions to protect confidential trade secrets, commercial property, and personal information associated with grant applications.
What changed
The NIH Center for Scientific Review issued a Federal Register notice announcing five closed virtual meetings in May 2026 for reviewing grant applications including PAR-25-444 Cancer Center Support Grant, RFA-HD-26-001 Development of Novel Infertility Technologies, and mentored training applications.
Research institutions and investigators seeking NIH funding should note that application reviews occur in closed sessions protected by trade secret and privacy exemptions. Applicants should monitor for funding announcements and reviewer feedback following these evaluation sessions.
What to do next
- Monitor NIH grant funding opportunities
- Review eligibility requirements for future submissions
Archived snapshot
Apr 10, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Notice
Center for Scientific Review; Notice of Closed Meetings
A Notice by the National Institutes of Health on 04/10/2026
PDF
Document Details
Document Dates
- Table of Contents
- Public Comments
- Regulations.gov Data
- Sharing
- Other Formats
- Public Inspection Published Document: 2026-06914 (91 FR 18473) Document Headings ###### Department of Health and Human Services
National Institutes of Health
Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Review of mentored training and research education applications.
Date: May 5-6, 2026.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Lee Warren Slice, MS, BA, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 867-5309, slicelw@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: AD/ADRD and Aging-Related Outcomes.
Date: May 5, 2026.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Sue Andersen, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 480-5404, sue.andersen-navalta@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR-25-444: Cancer Center Support Grant.
Date: May 6-7, 2026.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Mukesh Kumar, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 809 C, Bethesda, MD 20892, (301) 451-0359, mukesh.kumar3@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA-HD-26-001: Development of Novel or Improved Infertility Technologies.
Date: May 7, 2026.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Thomas John O'Farrell, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 402-8559, tom.ofarrell@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Support for Research Excellence and Research Enhancement Awards: Molecular Genetics, Cellular and Cancer Biology.
Date: May 7, 2026.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Sandip Bhattacharyya, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20852, (301) 594-7121, sandip.bhattacharyya@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Collaborative Applications: Aging Research Cooperative Research Centers (U19 Clinical Trial Optional).
Date: May 7-8, 2026.
Time: 9:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Shilpakala Ketha, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 761-6821, shilpa.ketha@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR-25-438: Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional).
Date: May 7, 2026.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Bruce Sundstrom, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-4481, SundstromJ@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Topics in Adaptive and Innate Immunity.
Date: May 7, 2026.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Poonam Pegu, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (240) 292-0719, poonam.pegu@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)
Dated: April 7, 2026.
Rosalind M. Niamke,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2026-06914 Filed 4-9-26; 8:45 am]
BILLING CODE 4140-01-P
Published Document: 2026-06914 (91 FR 18473)
Named provisions
Related changes
Get daily alerts for FR: National Institutes of Health
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from Health and Human Services Department.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when FR: National Institutes of Health publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.